Published in

American Association for the Advancement of Science, Science Translational Medicine, 624(13), 2021

DOI: 10.1126/scitranslmed.abk2267

Links

Tools

Export citation

Search in Google Scholar

β2-spectrin (SPTBN1) as a therapeutic target for diet-induced liver disease and preventing cancer development

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Targeting SBPTN1 with siRNA has the potential to treat NASH and prevent HCC.